Smoking does influence disease behaviour and impacts the need for therapy in Crohn's disease in the biologic era.

Autores de IIS La Fe

• 

  Pilar Nos Mateu

  Autor

• Belén Beltrán Niclós

  Autor

• Valentin Cabriada Nuño

  Autor

Participantes ajenos a IIS La Fe

• Nunes T
• Etchevers MJ
• Domènech E
• García-Sánchez V
• Ber Y
• Peñalva M
• Merino O
• Garcia-Planella E
• Casbas AG
• Esteve M
• Taxonera Samsó C
• Montoro Huguet M
• Gisbert JP
• Martín Arranz MD
• García-Sepulcre MF
• Barreiro-de Acosta M
• Alcaide Suárez N
• Saro Gismera C
• Cañas-Ventura A
• Gomollón F
• Panés J
• Tobacco-Eneida Study Group of GETECCU

Grupos

• Enfermedad Inflamatoria Intestinal

Abstract

Recently, the notion that smoking may adversely affect Crohn's disease (CD) outcomes has been challenged by the suggestion that the widespread use of immunosuppressants and anti-TNF drugs might offset the adverse effects of tobacco.